AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie net Litigation Reserve Charges / Adjustments ($M) ($M)
Form 10-Q / 10-K Contingencies Note
Latest, Q2 2026
-64
Period ended Jun 30, 2026
Change on a year earlier
+204.8%
-21 in Q2 2025
History
16 quarters
Since Q3 2021
Sources
11
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Litigation Reserve Charges / Adjustments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -64 | +204.8% | Form 10-Q (filed 2026-08-03) ↗ |
| Q1 2026 | Mar 31, 2026 | 150 | -120.6% | Form 10-Q (filed 2026-05-08) ↗ |
| Q4 2025 | Dec 31, 2025 | 136 | -18.6% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | -319 | -201.6% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | -21 | -153.8% | Form 10-Q (filed 2026-08-03) ↗ |
| Q1 2025 | Mar 31, 2025 | -729 | +5,975.0% | Form 10-Q (filed 2026-05-08) ↗ |
| Q4 2024 | Dec 31, 2024 | 167 | -170.2% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2024 | Sep 30, 2024 | 314 | -460.9% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 39 | – | Form 10-Q (filed 2025-08-04) ↗ |
| Q1 2024 | Mar 31, 2024 | -12 | – | Form 10-Q (filed 2025-05-09) ↗ |
| Q4 2023 | Dec 31, 2023 | -238 | +1,222.2% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2023 | Sep 30, 2023 | -87 | -222.5% | Form 10-Q (filed 2024-11-04) ↗ |
| Q4 2022 | Dec 31, 2022 | -18 | -112.7% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2022 | Sep 30, 2022 | 71 | -193.4% | Form 10-Q (filed 2023-11-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 142 | – | Form 10-K (filed 2024-02-20) ↗ |
| Q3 2021 | Sep 30, 2021 | -76 | – | Form 10-Q (filed 2022-11-04) ↗ |
Cite this data
StockData. (2026). AbbVie Net Litigation Reserve Charges / Adjustments ($M) ($M), quarterly Q3 2021–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/lit_adj_net
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.